With 104 fatalities in 24 hours, Delhi's COVID-19 death toll crosses 100-mark for first time

File image: Reuters

A day after reporting the highest single-day spike of over 8,000 new coronavirus cases, Delhi on November 12 recorded over 104 COVID-19 deaths in 24 hours--- the first time that daily death toll in the national capital has breached the 100 mark.

As per the daily COVID-19 bulletin released by the Delhi government, 7,053 new COVID-19 cases were reported on November 12 along with 104 deaths and 6,462 recoveries or discharges.

This takes the total number of coronavirus cases reported in the National Capital to 4,67,028, including 7,332 COVID-19 deaths and 4,16,580 recoveries or discharges. As per the Delhi government, the total number of active coronavirus cases in the state now stands at 43,116.

Delhi reports 7,053 new #COVID19 cases, 6,462 recoveries/discharges/migrations and 104 deaths in the last 24 hours.

Total cases rise to 4,67,028 including 4,16,580 recoveries/discharges/migrations and 7,332 deaths.

Active cases stand at 43,116: Delhi Government pic.twitter.com/xT66sQxNLF

COVID-19 Vaccine

Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Show

Related stories

• 
  Delhi: 5-year-old boy kidnapped, killed by father's driver, police suspect act of revenge
• 
  Fire breaks out at residential building in Indirapuram
• 
  Delhi noisier this Diwali; 23 monitoring stations breach sound limits despite curbs

— ANI (@ANI) November 12, 2020

Reports suggest that Delhi is currently going through a third wave of the coronavirus pandemic and is also grappling with an acute air pollution crisis.

Follow our coverage of the coronavirus crisis here